Internal Medicine · San Francisco, CA
NPI
1437189966
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
929 Clay St, #401
San Francisco, CA, 94108
Phone (415) 982-4100
Groups this clinician bills Medicare through
Medicare paid, 2024
$250K
5,399 services
Medicare patients, 2024
744
Average age 79
Drug cost, 2024
$2.9M
25,693 prescriptions
Company payments, 2025
$1,015
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gustin M Ho was code J0897 (injection, denosumab, 1 mg), 1,440 times for 22 patients. In total Gustin M Ho billed 5,399 services in 43 codes, and Medicare paid $250K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,440 | 22 | $0.00 | $6.13 |
| 99214 Office E&M - Established | Office | 1,109 | 388 | $97.14 | $108K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 388 | 58 | $0.68 | $264 |
| 93010 Electrocardiogram | Facility | 310 | 271 | $5.40 | $1,675 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 282 | 282 | $155.59 | $44K |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 276 | 274 | $29.16 | $8,047 |
| 99213 Office E&M - Established | Office | 273 | 164 | $71.66 | $20K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 267 | 265 | $23.55 | $6,287 |
| 96372 Injection Administration | Office | 177 | 76 | $11.96 | $2,117 |
| G0008 Administration of influenza virus vaccine | Office | 165 | 159 | $38.68 | $6,382 |
| 90662 Vaccine Product | Office | 95 | 94 | $81.72 | $7,763 |
| 93000 Electrocardiogram | Office | 63 | 62 | $13.71 | $864 |
| 90480 Vaccine Administration | Office | 62 | 55 | $50.75 | $3,147 |
| 91320 Vaccine Product | Office | 62 | 55 | $144.94 | $8,986 |
| 93306 Echocardiography (TTE/TEE) | Facility | 57 | 57 | $48.45 | $2,762 |
By year: 2022 $393K for 11,548 services; 2023 $303K for 7,765 services; 2024 $250K for 5,399 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 22 | 13 | $3.25 | $71.49 |
Medicare prescription drug claims, 2024
In 2024, the drug Gustin M Ho prescribed most often to Medicare patients was Atorvastatin Calcium, with 2,113 prescriptions and refills. In total Gustin M Ho wrote 25,693 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 2,113 | 6,169 | 614 | $17K |
| Losartan Potassium Generic | 1,432 | 4,132 | 398 | $11K |
| Amlodipine Besylate Generic | 1,345 | 3,977 | 395 | $9,066 |
| Metoprolol Succinate Generic | 874 | 2,499 | 251 | $12K |
| Metformin Hcl Generic | 731 | 2,120 | 205 | $5,558 |
| Triamcinolone Acetonide Generic | 704 | 735 | 259 | $6,680 |
| Omeprazole Generic | 634 | 1,739 | 222 | $4,931 |
| Simvastatin Generic | 590 | 1,730 | 157 | $4,165 |
| Jardiance Empagliflozin | 499 | 1,123 | 126 | $623K |
| Tamsulosin Hcl Generic | 430 | 1,206 | 133 | $5,197 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 403 | 1,170 | 120 | $6,152 |
| Pantoprazole Sodium Generic | 388 | 1,074 | 136 | $3,608 |
| Pioglitazone Hcl Generic | 358 | 1,024 | 100 | $5,926 |
| Eliquis Apixaban | 356 | 662 | 84 | $365K |
| Azithromycin Generic | 346 | 346 | 239 | $1,076 |
Brand drugs: 3,737 claims; generic drugs: 21,835 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gustin M Ho $1,015 ($1,015 in general payments such as food, travel and fees) from 11 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $209.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 8 | $209 |
| Pfizer Inc. PFE | 4 | $205 |
| GlaxoSmithKline, LLC. GSK | 7 | $195 |
| Amgen Inc. AMGN | 3 | $80.22 |
| Novo Nordisk Inc NVO | 4 | $67.23 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $65.77 |
| Sanofi Pasteur Inc. SNY | 2 | $62.67 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $47.32 |
| Lilly USA, LLC LLY | 1 | $30.48 |
| Merck Sharp & Dohme LLC MRK | 1 | $30.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.